Lipid alterations in the earliest clinically recognizable stage of Alzheimer's disease: implication of the role of lipids in the pathogenesis of Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Current Alzheimer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1567205052772786PMID 15977990
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples.

  2005cited by this paper
• Subcellular distribution, molecular dynamics and catabolism of plasmalogens in myocardium

  2004cited by this paper
• Cholesterol and the biology of Alzheimer's disease.

  2004cited by this paper
• ApoE and Clusterin Cooperatively Suppress Aβ Levels and Deposition: Evidence that ApoE Regulates Extracellular Aβ Metabolism In Vivo

  2004cited by this paper
• Modulation of Amyloid Precursor Protein Cleavage by Cellular Sphingolipids*

  2004cited by this paper
• Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease

  2004cited by this paper
• The Role of Cholesterol and Statins in Alzheimer's Disease

  2004cited by this paper
• The role of apolipoprotein E in lipid metabolism in the central nervous system

  2004cited by this paper
• Cholesterol Published, JLR Papers in Press, January 23, 2003. DOI 10.1194/jlr.R300007-JLR200

  2003cited by this paper
• Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia

  2003cited by this paper
• Cholesterol, synaptic function and Alzheimer's disease.

  2003cited by this paper
• Alzheimer's disease: the cholesterol connection

  2003cited by this paper
• Yin and Yang: complement activation and regulation in Alzheimer's disease.

  2003cited by this paper
• Regulation of TRP channels via lipid second messengers.

  2003cited by this paper
• Role of the ceramide-signaling pathways in ionizing radiation-induced apoptosis

  2003cited by this paper
• Inflammatory processes in Alzheimer's disease.

  2003cited by this paper
• Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease.

  2003cited by this paper
• Aberrant sphingomyelin/ceramide metabolic-induced neuronal endosomal/lysosomal dysfunction: potential pathological consequences in age-related neurodegeneration.

  2003cited by this paper
• Electrospray mass spectrometry of phospholipids.

  2003cited by this paper
• Withdrawal: Ceramide stabilizes β-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid β-peptide biogenesis

  2003cited by this paper
• Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics.

  2003cited by this paper
• Intracellular signal transduction pathways activated by ceramide and its metabolites.

  2003cited by this paper
• Cholesterol and Aβ aggregation

  2003cited by this paper
• Triglyceride accumulation protects against fatty acid-induced lipotoxicity

  2003cited by this paper
• Specificity and potential mechanism of sulfatide deficiency in Alzheimer's disease: an electrospray ionization mass spectrometric study.

  2003cited by this paper
• Neuronal endosomal/lysosomal membrane destabilization activates caspases and induces abnormal accumulation of the lipid secondary messenger ceramide.

  2003cited by this paper
• Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer’s disease

  2003cited by this paper
• Membrane dynamics, cholesterol homeostasis, and Alzheimer's disease Published, JLR Papers in Press, September 1, 2003. DOI 10.1194/jlr.R300010-JLR200

  2003cited by this paper
• Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration

  2003cited by this paper
• Modulating Sphingolipid Biosynthetic Pathway Rescues Photoreceptor Degeneration

  2003cited by this paper
• Novel Role for Apolipoprotein E in the Central Nervous System

  2003cited by this paper
• Lipid rafts Published, JLR Papers in Press, February 1, 2003. DOI 10.1194/jlr.R200021-JLR200

  2003cited by this paper
• Lipoproteins and lipid peroxidation in Alzheimer's disease.

  2003cited by this paper
• Tandem mass spectrometry in the study of fatty acids, bile acids, and steroids.

  2003cited by this paper
• Sphingoid bases and de novo ceramide synthesis: enzymes involved, pharmacology and mechanisms of action.

  2003cited by this paper
• A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease.

  2003cited by this paper
• Ceramide-driven stress signals in cancer and aging

  2003cited by this paper
• Sphingomyelin and ceramide in brain aging, neuronal plasticity and neurodegenerative disorders

  2003cited by this paper
• Cytokines in Sickle Cell Disease

  2003cited by this paper
• A turn of the sulfatide in Alzheimer's disease

  2003cited by this paper
• Carbonyl toxicology and Alzheimer's disease.

  2002cited by this paper
• Characterization and direct quantitation of ceramide molecular species from lipid extracts of biological samples by electrospray ionization tandem mass spectrometry.

  2002cited by this paper
• Acid sphingomyelinase-derived ceramide signaling in apoptosis.

  2002cited by this paper
• Apolipoprotein E, amyloid, and Alzheimer disease.

  2002cited by this paper
• Protein kinase C isoforms and lipid second messengers: a critical nuclear partnership?

  2002cited by this paper
• Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques.

  2002cited by this paper
• Alzheimer's disease: β‐Amyloid protein and tau

  2002cited by this paper
• Cholesterol, a Modulator of Membrane‐Associated Aβ‐Fibrillogenesis

  2002cited by this paper
• Tubulin is the endogenous inhibitor of the glyceraldehyde 3-phosphate dehydrogenase isoform that catalyzes membrane fusion: Implications for the coordinated regulation of glycolysis and membrane fusion

  2002cited by this paper
• Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

  2002cited by this paper
• Mitochondria and ceramide: intertwined roles in regulation of apoptosis.

  2002cited by this paper
• Sphingolipids in vascular biology.

  2002cited by this paper
• Galactolipids are molecular determinants of myelin development and axo-glial organization.

  2002cited by this paper
• Functional role of phospholipids in the nuclear events.

  2002cited by this paper
• Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress

  2002cited by this paper
• Contributions of mitochondrial alterations, resulting from bad genes and a hostile environment, to the pathogenesis of Alzheimer's disease.

  2002cited by this paper
• Mitochondria in Alzheimer's disease.

  2002cited by this paper
• Aβ conformational change is central to Alzheimer’s disease

  2002cited by this paper
• Apolipoprotein E: a major piece in the Alzheimer's disease puzzle

  2001cited by this paper
• Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry

  2001cited by this paper
• Alzheimer’s Disease and the Cerebellum: A Morphologic Study on Neuronal and Glial Changes

  2001cited by this paper
• Free-radical-induced oxidation of arachidonoyl plasmalogen phospholipids: antioxidant mechanism and precursor pathway for bioactive eicosanoids.

  2001cited by this paper
• Brain Membrane Phospholipid Alterations in Alzheimer's Disease

  2001cited by this paper
• Book Review: Plasmalogens: Workhorse Lipids of Membranes in Normal and Injured Neurons and Glia

  2001cited by this paper
• Two-dimensional analysis of phospholipids by capillary liquid chromatography/electrospray ionization mass spectrometry.

  2000cited by this paper
• LDL receptor‐related protein (LRP) in Alzheimer's disease: Towards a unified theory of pathogenesis

  2000cited by this paper
• Ceramide interaction with the respiratory chain of heart mitochondria.

  2000cited by this paper
• Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease.

  2000cited by this paper
• Phospholipid composition and levels are altered in Down syndrome brain.

  2000cited by this paper
• Synthesis and biological activity of glycolipids, with a focus on gangliosides and sulfatide analogs.

  2000cited by this paper
• Apolipoprotein E: far more than a lipid transport protein.

  2000cited by this paper
• Phospholipid composition and levels are not altered in fibroblasts bearing presenilin-1 mutations.

  2000cited by this paper
• Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease.

  2000cited by this paper
• Alzheimer's disease: its origin at the membrane, evidence and questions.

  2000cited by this paper
• Cross-talk between Phosphatidylinositol 3-Kinase and Sphingomyelinase Pathways as a Mechanism for Cell Survival/Death Decisions*

  2000cited by this paper
• Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders.

  2000cited by this paper
• Apolipoprotein E and Alzheimer's Disease

  2000cited by this paper
• Ceramide in the eukaryotic stress response.

  2000cited by this paper
• Oxidative stress and Alzheimer disease.

  2000cited by this paper
• Plasmalogens as endogenous antioxidants: somatic cell mutants reveal the importance of the vinyl ether.

  1999cited by this paper
• Cerebellar atrophy in Alzheimer's disease-clinicopathological correlations.

  1999cited by this paper
• Inhibition of peroxyl radical-mediated lipid oxidation by plasmalogen phospholipids and alpha-tocopherol.

  1999cited by this paper
• Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease.

  1999cited by this paper
• Oxidative Alterations in Alzheimer's Disease

  1999cited by this paper
• The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms.

  1999cited by this paper
• The protective role of plasmalogens in iron-induced lipid peroxidation.

  1999cited by this paper
• The biological significance of plasmalogens in defense against oxidative damage.

  1998cited by this paper
• Membrane Instability, Plasmalogen Content, and Alzheimer's Disease

  1998cited by this paper
• Reconstitution of membrane fusion between pancreatic islet secretory granules and plasma membranes: catalysis by a protein constituent recognized by monoclonal antibodies directed against glyceraldehyde-3-phosphate dehydrogenase.

  1998cited by this paper
• Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

  1998cited by this paper
• Galactosphingolipids and axono-glial interaction in myelin of the central nervous system

  1998cited by this paper
• Possible Link between Lipid Metabolism and Cerebral Amyloid Angiopathy in Alzheimer’s Disease: A Role for High-Density Lipoproteins?

  1998cited by this paper
• Plasmalogen-selective phospholipase A2 and its involvement in Alzheimer's disease.

  1998cited by this paper
• Reflections on the Great Plasmalogen Puzzle: Effector Mediated Signal Transduction Coupled to Glyceride Structures

  1998cited by this paper
• Peroxisomal Impairment in Niemann-Pick Type C Disease*

  1997cited by this paper
• Dramatic increase of α-hydroxyaldehydes derived from plasmalogens in the aged human brain

  1997cited by this paper
• Lipid biochemistry: functions of glycerolipids and sphingolipids in cellular signaling

  1997cited by this paper
• Magnetic Resonance Spectroscopic Changes in Alzheimer's Disease a

  1997cited by this paper
• A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide

  1997cited by this paper
• Chemistry and functional distribution of sulfoglycolipids.

  1997cited by this paper

• Phospholipid biomarkers in the diagnosis of patients with Alzheimer's disease

  2026influential citation
• Peroxisomes in Aging: Guardians of Cellular Resilience and Function

  2026cites this paper
• Hormonal modulation, mitochondria and Alzheimer’s prevention: the role of GLP-1 agonists and estrogens

  2025cites this paper
• First‐In‐Human Safety, Tolerability, and Pharmacokinetics of PPI‐1011, a Synthetic Plasmalogen Precursor

  2025cites this paper
• Association of the lipidome with type 1 diabetes and the mediated effect of metabolites: A Mendelian randomization study

  2025cites this paper
• Erythrocyte Membrane Fingerprints in the Veterinary Field: The Importance of Membrane Profiling and Its Application in Companion Animals

  2025cites this paper
• Investigation of the mechanism of Buyang Huanwu decoction in improving learning and memory impairment in Alzheimer's disease mice based on lipidomics

  2025cites this paper
• Screening for Alzheimer’s Disease Biomarkers Based on Metal Metabolism

  2025cites this paper
• Identification of Copper and Iron Metabolism Related Biomarkers in Alzheimer’s Disease

  2025cites this paper
• Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer’s disease in humans

  2025cites this paper
• The Changes in Plasmalogens: Chemical Diversity and Nutritional Implications—A Narrative Review

  2025cites this paper
• Metabolomic and transcriptomic remodeling of bone marrow myeloid cells in response to maternal obesity.

  2025cites this paper
• Acid sphingomyelinase as a pathological and therapeutic target in neurological disorders: focus on Alzheimer’s disease

  2024cites this paper
• Electroacupuncture at ST25 corrected gut microbial dysbiosis and SNpc lipid peroxidation in Parkinson’s disease rats

  2024cites this paper
• Vacuum promoted on-tissue derivatization strategy: Unravelling spatial distribution of glycerides on tissue

  2024cites this paper
• Lipid Wizard: Analysis Software for Comprehensive Two-Dimensional Liquid Chromatography-Mass Spectrometry-Based Lipid Profiling.

  2024cites this paper
• Lipidomics Analysis Deepen Understanding the Molecular Mechanisms in a Gouty Model Induced by Combination of MSU Crystals Injection and High-Fat Diet Feeding and the Intervention Mechanisms of Allopurinol

  2024cites this paper
• Myelin Lipid Alterations in Neurodegenerative Diseases: Landscape and Pathogenic Implications

  2024cites this paper
• COVID‐19 vaccine adverse events: Evaluating the pathophysiology with an emphasis on sulfur metabolism and endotheliopathy

  2024influential citation
• A novel inducible animal model for studying chronic plasmalogen deficiency associated with Alzheimer's disease.

  2024cites this paper
• Ether Lipid-Mediated Antioxidant Defense in Alzheimer’s Disease

  2023cites this paper
• Multi-omics analyses reveal novel effects of PLCγ2 deficiency in the mouse brain

  2023cites this paper
• Contribution of 25-hydroxycholesterol to the cross-interaction of the immune and nervous systems

  2023cites this paper
• Therapeutic potential of a modified Mediterranean ketogenic diet in reversing the peripheral lipid signature of Alzheimer's disease

  2023cites this paper
• Chronic inflammation, neuroglia dysfunction, and plasmalogen deficiency as a new pathobiological hypothesis addressing the overlap between post-COVID-19 symptoms and myalgic encephalomyelitis/chronic fatigue syndrome.

  2023cites this paper
• Adult-Onset CNS Sulfatide Deficiency Causes Sex-Dependent Metabolic Disruption in Aging

  2023cites this paper
• Molecular and biophysical features of hippocampal “lipid rafts aging” are modified by dietary n‐3 long‐chain polyunsaturated fatty acids

  2023cites this paper
• Lipidomics analysis facilitate insight into the molecular mechanisms of urate nephropathy in a gout model induced by combination of MSU crystals injection and high-fat diet feeding

  2023cites this paper
• Sulfatide Deficiency, an Early Alzheimer’s Lipidomic Signature, Causes Brain Ventricular Enlargement in the Absence of Classical Neuropathological Hallmarks

  2022cites this paper
• TREM2 dependent and independent functions of microglia in Alzheimer’s disease

  2022cites this paper
• Regulation of plasmalogen metabolism and traffic in mammals: The fog begins to lift

  2022cites this paper
• Plasmalogens Eliminate Aging-Associated Synaptic Defects and Microglia-Mediated Neuroinflammation in Mice

  2022cites this paper
• Sex Differences in the Metabolome of Alzheimer’s Disease Progression

  2022cites this paper
• Integrative omics – An arsenal for drug discovery

  2022cites this paper
• Metabolomic Profiling of Peripheral Plasma by GC-MS and Correlation With Size of Uterine Leiomyomas

  2022cites this paper
• Pharmacokinetics, Mass Balance, Excretion, and Tissue Distribution of Plasmalogen Precursor PPI-1011

  2022cites this paper
• Targeted Plasmalogen Supplementation: Effects on Blood Plasmalogens, Oxidative Stress Biomarkers, Cognition, and Mobility in Cognitively Impaired Persons

  2022cites this paper
• The physiological functions of human peroxisomes.

  2022cites this paper
• The synaptic lipidome in health and disease.

  2022cites this paper
• Brain ethanolamine phospholipids, neuropathology and cognition: A comparative post-mortem analysis of structurally specific plasmalogen and phosphatidyl species

  2022cites this paper
• Reassessment of Pioglitazone for Alzheimer’s Disease

  2021cites this paper
• Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease.

  2021cites this paper
• Lipidomics Revealed Aberrant Metabolism of Lipids Including FAHFAs in Renal Tissue in the Progression of Lupus Nephritis in a Murine Model

  2021cites this paper
• The foundations and development of lipidomics

  2021cites this paper
• Association of Lipidomics Signatures in Blood with Clinical Progression in Preclinical and Prodromal Alzheimer’s Disease

  2021cites this paper
• A Lipidomics Atlas of Selected Sphingolipids in Multiple Mouse Nervous System Regions

  2021cites this paper
• Plasmalogens and Chronic Inflammatory Diseases

  2021cites this paper
• Unravelling the capacity of hydroxytyrosol and its lipophenolic derivates to modulate the H2O2-induced isoprostanoid profile of THP-1 monocytes by UHPLC-QqQ-MS/MS lipidomic workflow

  2021cites this paper
• Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer’s disease-like neuroinflammation and cognitive impairment

  2021cites this paper
• Lipidomics of aging

  2021cites this paper
• Plasmalogens, platelet-activating factor and beyond – Ether lipids in signaling and neurodegeneration

  2020cites this paper
• RECOGNITION AND AVOIDANCE OF ION SOURCE-GENERATED ARTIFACTS IN LIPIDOMICS ANALYSIS.

  2020cites this paper
• Lipid-based biomarkers for CVD, COPD, and aging - A translational perspective.

  2020cites this paper
• How Do Ethanolamine Plasmalogens Contribute to Order and Structure of Neurological Membranes?

  2020cites this paper
• Recent advances in the mass spectrometric analysis of glycosphingolipidome - A review.

  2020cites this paper
• Metabolomics markers in Neurology: current knowledge and future perspectives for therapeutic targeting

  2020cites this paper
• Development of MALDI Mass Spectrometry Imaging Methods for Probing Spatial Lipid Biochemistry of Amyloid Plaques in Alzheimer's Disease

  2020cites this paper
• Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau

  2020cites this paper
• Evaluating a targeted multiple reaction monitoring approach to global untargeted lipidomic analyses of human plasma.

  2020cites this paper
• Disturbed neurotransmitter homeostasis in ether lipid deficiency

  2019cites this paper
• Tutorial on lipidomics.

  2019cites this paper
• Plasmalogens and Alzheimer’s disease: a review

  2019cites this paper
• Insulin Resistance and Oligodendrocyte/Microvascular Endothelial Cell Dysfunction as Mediators of White Matter Degeneration in Alzheimer’s Disease

  2019cites this paper
• Novel strategies for enhancing shotgun lipidomics for comprehensive analysis of cellular lipidomes.

  2019cites this paper
• Lipid class composition of membrane and raft fractions from brains of individuals with Alzheimer's disease

  2019cites this paper
• Lipidomic characterization of extracellular vesicles in human serum

  2019cites this paper
• The protection of indolealkylamines on LPS-induced inflammation in zebrafish.

  2019cites this paper
• Searching for Potential Lipid Biomarkers of Parkinson’s Disease in Parkin-Mutant Human Skin Fibroblasts by HILIC-ESI-MS/MS: Preliminary Findings

  2019cites this paper
• Diet and Nutrition, and their Influence on Alzheimer's Disease and other Neurodegenerative Diseases

  2019cites this paper
• Evidence from ITIR-FCS Diffusion Studies that the Amyloid-Beta (Aβ) Peptide Does Not Perturb Plasma Membrane Fluidity in Neuronal Cells.

  2018cites this paper
• Analysis of eicosanoid oxidation products in Alzheimer brain by LC‐MS with uniformly 13C‐labeled internal standards

  2018cites this paper
• Omega‐3 fatty acids modulate the lipid profile, membrane architecture, and gene expression of leiomyoma cells

  2018cites this paper
• Characterization of potential plasma biomarkers related to cognitive impairment by untargeted profiling of phospholipids using the HILIC-ESI-IT-TOF-MS system

  2018cites this paper
• Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer’s Disease Mimic Accelerated Aging

  2018cites this paper
• Amyloid-β Peptide Triggers Membrane Remodeling in Supported Lipid Bilayers Depending on Their Hydrophobic Thickness.

  2018cites this paper
• Lipidomics Reveals Changes in Metabolism, Indicative of Anesthetic-Induced Neurotoxicity in Developing Brains.

  2018cites this paper
• Brain metabolomics : a new comprehensive metabolic profiling approach to Alzheimer's disease pathology using LC-MS and GC-MS

  2018cites this paper
• The Heart and Mind Connection: Biomarkers of Cognitive Response to Exercise in Coronary Artery Disease

  2017influential citation
• Structural and functional roles of ether lipids

  2017cites this paper
• Reduced muscle strength in ether lipid‐deficient mice is accompanied by altered development and function of the neuromuscular junction

  2017cites this paper
• The phospholipid composition of the human entorhinal cortex remains relatively stable over 80 years of adult aging

  2017cites this paper
• From peroxisomal disorders to common neurodegenerative diseases – the role of ether phospholipids in the nervous system

  2017influential citation
• Shotgun lipidomics in substantiating lipid peroxidation in redox biology: Methods and applications

  2017cites this paper
• Neuronal Cholesterol Accumulation Induced by Cyp46a1 Down-Regulation in Mouse Hippocampus Disrupts Brain Lipid Homeostasis

  2017influential citation
• The effect of lead exposure on fatty acid composition in mouse brain analyzed using pseudo-catalytic derivatization.

  2017cites this paper
• Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences.

  2016cites this paper
• Recent advances in lipidomics for disease research.

  2016cites this paper
• Altered brain energetics induces mitochondrial fission arrest in Alzheimer’s Disease

  2016cites this paper
• Lipidomics for Health and Disease

  2016cites this paper
• Serum ethanolamine plasmalogens improve detection of cognitive impairment among elderly with high excretion levels of urinary myo-inositol: A cross-sectional study.

  2016cites this paper
• Novel advances in shotgun lipidomics for biology and medicine.

  2016cites this paper
• Natural Modulators of Amyloid formation in Alzheimer's disease

  2016cites this paper
• High Content, Multi-Parameter Analyses in Buccal Cells to Identify Alzheimer's Disease.

  2016cites this paper
• Regulation of Sphingolipid Biosynthesis by the Morphogenesis Checkpoint Kinase Swe1*

  2015cites this paper
• Plasmalogen precursor analog treatment reduces levodopa-induced dyskinesias in parkinsonian monkeys.

  2015cites this paper
• Application of lipidomics in nutrition research

  2015cites this paper
• Homeostasis of phospholipids — The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens

  2015cites this paper
• Peroxisomes in brain development and function

  2015cites this paper
• Lipidomics of human brain aging and Alzheimer's disease pathology.

  2015cites this paper
• Lipids under stress – a lipidomic approach for the study of mood disorders

  2015cites this paper